Two-component flavoprotein monooxygenases are emerging biocatalysts that generally consist of a monooxygenase and a reductase component. Here we show that Rhodococcus opacus 1CP encodes a multifunctional enantioselective flavoprotein monooxygenase system composed of a single styrene monooxygenase (SMO) (StyA1) and another styrene monooxygenase fused to an NADH-flavin oxidoreductase (StyA2B). StyA1 and StyA2B convert styrene and chemical analogues to the corresponding epoxides at the expense of FADH 2 provided from StyA2B. The StyA1/StyA2B system presents the highest monooxygenase activity in an equimolar ratio of StyA1 and StyA2B, indicating (transient) protein complex formation. StyA1 is also active when FADH 2 is supplied by StyB from Pseudomonas sp. VLB120 or PheA2 from Rhodococcus opacus 1CP. However, in both cases the reductase produces an excess of FADH 2 , resulting in a high waste of NADH. The epoxidation rate of StyA1 heavily depends on the type of reductase. This supports that the FADH 2 -induced activation of StyA1 requires interprotein communication. We conclude that the StyA1/StyA2B system represents a novel type of multifunctional flavoprotein monooxygenase. Its unique mechanism of cofactor utilization provides new opportunities for biotechnological applications and is highly relevant from a structural and evolutionary point of view.The environmentally harmful hydrocarbon styrene is readily biodegradable by various classes of microorganisms covering Gram-negative and Gram-positive bacteria as well as fungi (e.g., ascomycetes). Two major pathways for styrene mineralization have been described (reviewed in references 23, 26, and 33); of these, the most common one is initiated by a monooxygenase-catalyzed epoxidation of the vinyl side chain. Due to their biotechnological potential, the styrene monooxygenases (SMOs) involved in this reaction have received considerable attention. Most SMOs have been described for pseudomonads and were investigated for their biochemical properties (5,13,27,31,46) and their biotechnological applicability in cell-free (16, 17) or whole-cell systems (3,12,28,29,30,32,37). All SMOs investigated thus far convert styrene in a highly enantioselective manner to (S)-styrene oxide, which is a useful precursor for several chiral synthons and pharmaceuticals (2,6,14,26,34). Moreover, the relaxed substrate specificity of SMOs allows an enantioselective conversion of substituted styrene derivatives and structurally related compounds, like indene and dihydronaphthalene, as well as phenylalkylsulfides ( Fig. 1) (17, 40, 45), thus increasing their biocatalytic potential.Typical SMOs of pseudomonads consist of two enzymatically active protein components encoded by genes that are usually clustered adjacent to each other (styA and styB) (Fig. 2a) (26,43,46). The flavin reductase subunit (StyB) reduces flavin adenine dinucleotide (FAD) at the expense of NADH.The monooxygenase subunit (StyA) then utilizes the reduced flavin (FADH 2 ) to activate molecular oxygen for styrene attack (Fig. 2b)....